About Matthew Hammond
Form D filings for Jnana Therapeutics from 2021 to 2024 list Matthew Hammond as director.
Matthew Hammond first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Matthew Hammond in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Hammond works with at each company, as listed on that company's latest Form D.
Jnana Therapeutics Inc. · Form D/A, Jan 26, 2024
AC
Annie Chen
Director
DP
Douglas Pagan
Chief Financial Officer and Chief Operating Officer
RJ
Ronald Renaud, Jr.
Director
GV
George Vratsanos
Chief Medical Officer and Head of R&D
CR
Carlo Rizzuto
Director
TM
Terrance McGuire
Director
JK
Joanne Kotz
Chief Executive Officer, Treasurer, Secretary and Director
DN
Donald Nicholson
Director
CB
Caroline Beer
Chief Business Officer
BC
Brian Cali
Director